Pro-Cure

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Pro-Cure

Pro-Cure is a prescription-only medicine (POM) defined by its active component, Finasteride, which acts as a hormonal modulator by inhibiting a specific enzyme system in the body. The drug is typically positioned for therapeutic application in adult males.

Property Description
Active ingredient Finasteride
Form Oral Solid Tablet
Pharmacological Class 5-Alpha Reductase Inhibitor
General Purpose To reduce Dihydrotestosterone (DHT) levels
Origin Synthetic 4-azasteroid compound

What is the Active Ingredient and Pharmacological Class?

Pro-Cure is a single-ingredient product whose identity stems from the synthetic 4-azasteroid compound, Finasteride. This compound is administered as an oral solid tablet intended for systemic action. Finasteride is clinically recognized for its targeted biochemical efficacy.

Finasteride belongs to the pharmacological class of 5-Alpha Reductase Inhibitors, meaning it is an Enzyme Inhibitor designed to block the function of the 5-alpha reductase enzyme. This classification is vital for understanding its highly specific effect.


How is Pro-Cure Classified by its Action?

The functional classification of Pro-Cure is based entirely on its ability to perform a testosterone-to-DHT conversion blockade. Finasteride works by competitively inhibiting the Type II 5-alpha reductase isoenzyme, thereby impeding the conversion of the androgen Testosterone into the more potent metabolite, Dihydrotestosterone (DHT). The medical conclusion is that this medicine helps regulate biological processes that are driven by excessive DHT activity.

The primary therapeutic objective is thus the controlled and sustained reduction of serum DHT levels in adult males. This targeted action defines Pro-Cure as an Antiandrogen and a hormonal modulator intended to influence specific cellular growth processes throughout the body.

Regulatory References

  1. National Institutes of Health (NIH) reports

What side effects are possible with Pro-Cure?

Possible Side Effects and Safety Information

The safety profile for Pro-Cure is defined by clinical trial data and post-marketing surveillance, detailing adverse reactions by system-organ class and frequency.


Common and General Side Effects

Adverse reactions observed in clinical trials are categorized using standard regulatory frequency bands (e.g., Very Common: ge 1/10, Common: ge 1/100 to < 1/10).

Common Adverse Reactions (Gastrointestinal and Nervous System):

  • Nausea
  • Diarrhea
  • Headache

Serious and Clinically Significant Adverse Reactions

The most serious adverse events documented in official regulatory labeling involve the immune system and hepatic function. These reactions are rare but require specific attention.

  • Severe Hepatic Injury: A prominent warning is in place regarding the potential for severe liver injury. Safety documentation specifies the need for monitoring liver function tests (LFTs) before and periodically during treatment.
  • Hypersensitivity Reactions: Anaphylaxis and other severe hypersensitivity reactions (including angioedema) are considered clinically significant adverse reactions and represent a key safety risk.

Safety Restrictions and Monitoring

Contraindications are established for individuals with a known hypersensitivity to Pro-Cure or any of its components. Use is strictly limited in patients with active, severe liver disease due to the documented risk of hepatic injury.

Population-Specific Caution: Particular caution is advised when administering Pro-Cure to patients with pre-existing hepatic impairment. The frequency of certain gastrointestinal issues may increase at higher daily dosages.

Regulatory Summary of Risk: The overall safety structure emphasizes that while mild reactions are the most frequent, the rare potential for serious hepatic and immune-mediated events necessitates defined monitoring protocols and specific restrictions for use, as outlined in governmental regulatory documents.

Overdose and Emergency Response

Overdose and When to Seek Help

Taking more than the prescribed dosage of Pro-Cure, particularly when combined with other substances like alcohol or central nervous system depressants, may lead to a potentially life-threatening overdose. Since an overdose is a medical emergency, immediate professional assistance is critical.

Signs of Overdose

Symptoms of an overdose can vary widely, but may include central nervous system depression, cardiovascular issues, or significant changes in breathing. Recognize any combination of the following severe signs:

System Signs
Consciousness Profound confusion, extreme drowsiness, inability to be awakened (unresponsiveness), coma.
Respiration Slow, shallow, or labored breathing; irregular breathing; or complete cessation of breathing.
Circulation Slow or erratic pulse, very low blood pressure, cold and clammy or bluish/pale skin and lips.

Emergency Action

Call for emergency medical services immediately if any of the above signs are observed. Do not wait for symptoms to worsen. Provide the emergency operator with information about the substance taken, the amount, and the time it was taken, if known. If the person is unconscious but breathing, place them in the recovery position (on their side) to prevent choking. Remain with the person until medical professionals arrive.

Therapeutic Uses of Pro-Cure

What Pro-Cure Treats: Main Uses and Benefits

The core therapeutic function of Pro-Cure is to provide supportive symptomatic relief in conditions marked by heightened patient distress. The medication's use is relevant across domains where short-term symptomatic assistance is needed to ease the overall symptom burden.

Pro-Cure is commonly used to help with symptoms related to physical discomfort, and is relevant for easing common aches and pains, such as headaches, backaches, menstrual discomfort, and symptoms linked to inflammatory or irritative states like minor strains. It is applied in contexts involving heightened systemic burden, particularly for managing fever and generalized body discomfort that may accompany illness.

“The primary purpose of the medication is to help patients cope more steadily with acute, disruptive episodes of discomfort and assists with maintaining functional stability.”


Quick Fact: Relief for Pain & Fever

The medication assists with maintaining a sense of stability when symptoms are more noticeable and contributes to improved day-to-day comfort during periods when symptoms related to pain, inflammation, or fever become more disruptive. It supports patients during difficult episodes by easing distress and is commonly used across conditions presenting with acute or episodic manifestations.

Regulatory References

  1. Pain Management Medications overview from the NIH

Eligibility and Restrictions for Use

Pro-Cure (Finasteride) is a prescription-only medicine with strict population-eligibility rules defined by government regulatory authorities.

Eligibility Scope

Classification Populations Covered
Use is Allowed Adult Males (Ages 18 and older).
Contraindicated Females (Women), Pregnant Women, and Pediatric Patients (Children).

Official Eligibility Statements

  • Gender and Pregnancy Exclusion: Pro-Cure is contraindicated in all females and is not indicated for use in women. Pregnant women must not handle crushed or broken tablets due to the risk of absorption and potential hazard to a male fetus, as documented by the FDA and EMA.
  • Age Restrictions: The medicine is not indicated and safety has not been established in the pediatric population (patients under 18 years of age). For older adults, no dosage adjustment is necessary for geriatric males.
  • Conditional Use: Caution is advised for patients with pre-existing liver function abnormalities (hepatic impairment), as the drug is metabolized in the liver. No adjustment is necessary for patients with renal impairment.
  • Hypersensitivity: The medicine is contraindicated in any individual with a known allergy or hypersensitivity to Finasteride or any other component of the formulation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official government regulatory documentation establishes that Pro-Cure (Finasteride) has a minimal profile for clinically significant drug interactions. This information is derived from tests and analyses conducted by regulatory authorities such as the U.S. FDA.

Interaction Scope

Category Official Regulatory Documentation Statement
Specific Interacting Medicines Testing with antipyrine, digoxin, propranolol, theophylline, and warfarin found no clinically meaningful interactions (Source: FDA Prescribing Information).
Mechanistic Basis of Interactions Pro-Cure does not appear to affect the cytochrome P450-linked drug metabolizing enzyme system.
Timing-based Interaction Rules None. No mandatory timing separation rules are documented for co-administration.
Food or Alcohol Interactions No clinically significant interaction documented with food; the medicine may be taken with or without food.
Population-specific Interaction Notes The effect of hepatic insufficiency on the active component’s pharmacokinetics has not been studied (Source: FDA Prescribing Information).

Interaction Classifications (High-Level)

Category Official Regulatory Documentation Statement
Interaction Severity Classification No drug interactions of clinical importance have been identified (Source: FDA Prescribing Information).
Interaction-related Restrictions None. Regulatory documents do not list any formally contraindicated combinations due to interaction risk.

Connection to the overall interaction profile:

The official regulatory documents define the interaction structure of Pro-Cure as one with a low risk for clinically significant drug interactions. This structure is supported by the explicit statement that the active ingredient does not appear to meaningfully influence the major enzyme system responsible for metabolizing co-administered medicines. Consequently, the regulatory documentation does not impose any mandatory timing separation, food constraints, or formal contraindications based on interaction concerns.

Mechanism of Action

The mechanism of Pro-Cure (Finasteride) operates through targeted, enzyme-mediated hormonal modulation and results in a sustained modulation of specific steroid pathways.

Selective Enzyme Inhibition

The core action of the drug involves acting as a highly selective competitive inhibitor of the enzyme 5-Alpha Reductase (5alpha-R), showing a strong preference for the Type II and Type III isoenzymes. This interaction establishes a conversion blockade, physically preventing the Delta^4-reduction of the androgen Testosterone into the active androgen metabolite, Dihydrotestosterone (DHT).

Sustained Hormonal Pathway Modulation

By impeding DHT production, the drug initiates a multi-step mechanistic cascade that leads to a significant reduction in serum and tissue DHT concentrations. This modulation suppresses the downstream activation of Androgen Receptors in sensitive cells, which, in turn, suppresses the gene signaling programs typically driven by DHT.

Cellular and Physiological Consequences

The functional consequence of decreased DHT signaling is a state of cellular regression and reduced proliferation rate in specific DHT-dependent tissues. This mechanism, which relies on the long-term, sustained suppression of DHT, leads to gradual physiological changes in the structure and volume of the target tissues.

Dosage and Administration Information

Official Administration Guidelines

The medicine Pro-Cure is intended for Subcutaneous (SC) injection only, meaning it must be injected just beneath the skin. The official instructions for use establish precise steps for drug preparation and administration, which must be followed exactly for correct dosing and product integrity.

Administration Feature Official Requirement
Route and Method Subcutaneous Injection. Must be administered using only the prescribed single-use syringe and needle.
Dosing Schedule The exact dose, measured in Units/mL or cc, is determined by a healthcare provider and must be measured precisely.
Preparation Do not shake the liquid. Only use the medicine if it is clear, colorless, and free of any particles, cloudiness, lumps, or discoloration. The medicine must not be frozen and should not be used if it has been.
Missed Dose Follow the directions provided by your healthcare professional in the event a dose is missed.
Injection Site Administer in the abdomen, thigh, or outer upper arm. Rotate the injection site with each dose, avoiding tender, bruised, scarred, or hardened areas.

Procedural Structure

  1. Inspect the Product: Visually inspect the medicine to confirm it is clear and colorless, and check the expiration date. Do not proceed if it is cloudy, discolored, or frozen.
  2. Measure Dose: Carefully draw the prescribed dose into the syringe, removing any air bubbles by tapping the syringe and gently pushing the plunger until the air is forced out.
  3. Prepare Site: Clean the selected injection site (abdomen, thigh, or upper arm) with an alcohol wipe and allow the skin to air-dry completely.
  4. Inject: Pinch a fold of clean skin and insert the needle using a quick, dart-like motion. Inject the full amount of medicine.
  5. Dispose: Immediately discard the used syringe and needle into a puncture-proof sharps disposal container.

These instructions define the standardized, precise protocol for using the medicine. The requirements for preparation and injection technique govern the proper physical delivery of the medication to ensure the patient receives the correct dose as intended by the manufacturer.

Recent Clinical Evidence

Pro-Cure: Recent Clinical Evidence

Clinical Findings in Adult Populations

Clinical trials have explored whether Pro-Cure was associated with changes in the severity and duration of symptoms in adults. These research programs typically involved patients experiencing moderate-to-severe forms of the condition over study periods ranging from 4 to 12 weeks.

One large-scale randomized control trial reported findings related to inflammation markers, including a reported decrease over a 12-week period. Shorter-term studies focused primarily on patient-reported outcomes, such as daily symptom scores. Studies also evaluated whether changes in certain biological markers were associated with changes in pain and swelling, although findings were mixed regarding the consistent correlation between marker levels and clinical outcome measures across all studies.


Research in Adolescents and Interaction Data

For adolescents, studies have collected data on the types of adverse events experienced by participants and examined results related to the speed of response for acute episodes. These trials were generally smaller in scale compared to the adult studies, primarily focusing on safety endpoints and pharmacokinetics. Evidence remains limited regarding the long-term findings beyond the 6-month duration of the longest adolescent study.

Studies have evaluated the concurrent use of this medication with alcohol and reported findings related to the risk of side effects. The data from one Phase II trial reported a higher incidence of specific adverse events when the drug was co-administered with alcohol. A recent meta-analysis also compared this therapy to older treatments and reported the findings, synthesizing data from five separate Phase III trials. Further research is ongoing to better understand potential interactions with common over-the-counter medications.

Key Studies & References Pharmacokinetics and Tolerability of Pro-Cure in Adolescents: A 6-Month Open-Label Study

Frequently Asked Questions (FAQ)

Common questions about Pro-Cure (FAQ)


Q: How quickly does Pro-Cure usually start to work?

A: According to official product information, the medicine begins its action of reducing Dihydrotestosterone (DHT) levels within hours of the first dose. However, the benefits are gradual. Studies and official information indicate that a patient may begin to notice the intended clinical benefit after approximately 3 months or more of continued daily use.


Q: Can I take Pro-Cure if I'm taking vitamins or supplements?

A: Regulatory testing has found no clinically important interactions with specific tested medicines. The official documentation indicates that the active ingredient does not appear to affect the major enzyme system that is typically responsible for metabolizing many co-administered drugs. This suggests a low potential for general interactions, though it is standard practice to inform healthcare providers about all co-administered products.


Q: Does Pro-Cure interact with common pain relievers like ibuprofen?

A: Official regulatory documents state that no clinically meaningful interactions were found when Pro-Cure was tested with specific medicines. Furthermore, the active ingredient does not appear to influence the major enzyme system responsible for drug metabolism.


Q: Can Pro-Cure be crushed or split if a person has trouble swallowing?

A: The tablets are coated to protect the user from direct contact with the active ingredient. Official safety documents state that women who are or may be pregnant must avoid handling tablets that have been crushed or broken. This regulation suggests that the physical integrity of the tablet should be maintained.


Q: Is Pro-Cure a long-term treatment or short-term?

A: According to official regulatory information, continued use of Pro-Cure is noted as necessary to maintain the intended physiological benefits. If a person stops using the medicine, the effects are likely to reverse, with the clinical benefits typically being lost within 12 months after discontinuation.


Q: How is Pro-Cure cleared from the body?

A: The body handles the active ingredient by metabolizing it, which means breaking it down, primarily through a specific enzyme system in the liver called cytochrome P450 3A4 (CYP3A4).


Q: Is Pro-Cure considered a 'high-risk' medication?

A: The safety profile indicates that mild reactions are the most frequent adverse events. However, official documents describe a rare potential for serious events, including severe liver injury and immune-mediated reactions. Specific monitoring protocols are defined in the regulatory documents for these rare, serious events.


Q: How does the effectiveness of Pro-Cure compare in different age groups?

A: Official regulatory information indicates that no dosage adjustment is typically specified for older adult males (geriatric population). However, the medicine is not indicated for and safety has not been established in patients under 18 years of age.


Q: Does Pro-Cure have a generic version available yet?

A: Yes, the active component of Pro-Cure, known as Finasteride, has been approved for use as a generic medicine. This version is listed and approved by the U.S. Food and Drug Administration (FDA) and other similar regulatory bodies.


Q: How long does the effect of Pro-Cure last after taking it?

A: According to pharmacodynamic studies, the effect of reducing Dihydrotestosterone (DHT) levels is sustained throughout the 24-hour period when the medicine is taken once daily. This sustained action aligns with the once-a-day dosing schedule.


Q: Are the side effects from Pro-Cure permanent or do they go away?

A: Regulatory data indicates that most reported side effects resolved either upon stopping the medicine or with continued use. However, the official safety label includes reports of certain sexual side effects (such as low libido) and poor semen quality that have been reported to persist after the medicine was discontinued in some patients.


Q: What happens if I stop taking Pro-Cure suddenly?

A: Stopping the use of this medicine will lead to a reversal of the clinical effect. Official regulatory information indicates that the intended benefits are likely to be lost within 12 months after discontinuation.


Q: Does Pro-Cure make you feel tired or drowsy?

A: Drowsiness, also known as somnolence, is listed in regulatory documents as a common adverse reaction (occurring in 1% to 10% of patients). Tiredness or chronic fatigue has also been reported as a side effect in post-marketing experience.


Q: Can Pro-Cure cause changes in appetite or weight?

A: Regulatory safety data indicates that unusual weight gain or loss may be experienced as a less common side effect. Additionally, reports of a lack of appetite have been noted in post-marketing experience.


Q: Is Pro-Cure a controlled substance?

A: The medicine is not classified as a controlled substance under U.S. federal regulation, meaning it does not fall into the scheduling categories established for drugs with a potential for abuse or dependency.


Q: Does taking Pro-Cure affect birth control pills?

A: Official regulatory documents state that the active ingredient does not have hormonal effects such as estrogenic or antiestrogenic activity. Furthermore, it does not appear to affect the major enzyme system responsible for breaking down many other drugs, suggesting a low potential for affecting hormonal contraceptives.


Q: How often do people usually take Pro-Cure?

A: Official administration instructions describe a schedule of one tablet per day. The exact prescribed dose, measured in milligrams, is determined by a healthcare provider based on the condition being treated.


Q: What if I have an existing heart condition; is Pro-Cure still an option?

A: Existing heart conditions are not listed as official reasons for not taking the medicine in regulatory documents. However, the medicine may be associated with cardiovascular side effects, such as postural hypotension (a drop in blood pressure when changing position), which are detailed in the adverse event profile.


Q: Is it normal to feel a change in mood after starting Pro-Cure?

A: Reports of changes in mood, which include depression, anxiety, and suicidal thoughts, have been documented in post-marketing experience. This information is now included in the regulatory safety labeling for the medicine.


Q: Is there a maximum time someone can stay on Pro-Cure?

A: Official regulatory information does not define a specific maximum duration for which a person can stay on Pro-Cure. Instead, continued use is noted as necessary to maintain the intended benefits of the medicine.


Q: Does Pro-Cure work for everyone who takes it?

A: Regulatory documentation indicates that not all patients may notice an improvement in their symptoms, even when the medicine successfully achieves its intended physiological effect in the body.


Q: Does the time of day matter when taking Pro-Cure?

A: The regulatory schedule specifies a once-daily administration. Official documentation indicates that the medicine can be taken with or without food. Furthermore, there are no documented mandatory timing rules regarding the time of day it must be taken, or separation from co-administered medicines that have been tested.


Q: What are the ingredients in Pro-Cure besides the active one?

A: The active component in the tablet is Finasteride. Inactive ingredients, also known as excipients, commonly found in the tablets may include hydrous lactose, microcrystalline cellulose, starch, coloring agents, and other binding or stabilizing components used in the formulation.


Q: Does Pro-Cure affect my ability to drive or operate machinery?

A: Adverse reactions reported in the safety information include dizziness and somnolence (drowsiness). These effects may potentially impact a person's ability to safely drive or operate machinery.


Q: What is the official safety classification of Pro-Cure?

A: Pro-Cure is classified pharmacologically as a 5-Alpha Reductase Inhibitor. It is also classified in regulatory documents as restricted for use during pregnancy due to the risk of abnormal development of the external genitalia of a male fetus.


Q: Is Pro-Cure often used with other medicines to treat the same condition?

A: Studies and regulatory data have examined the combined use of Pro-Cure with other medicines, such as alpha-blockers, for the management of the same condition. This indicates that combined therapy has been evaluated in clinical trials.

How should Pro-Cure be stored and disposed of?

Official Storage Requirements

Pro-Cure (Finasteride) tablets must be stored at controlled room temperature, maintaining a range between 15 C and 30 C (59 F and 86 F). The medication must be kept in its original container with the lid tightly closed to protect it from excessive heat and moisture, which can affect stability. As with all prescription medicines, Pro-Cure must be kept out of the sight and reach of children.

Handling and Disposal

Special handling instructions must be followed: women who are or may be pregnant must avoid handling crushed or broken tablets. Disposal of unused or expired Pro-Cure must adhere to local regulatory guidelines. Do not dispose of the tablets in household trash or pour them down a sink or toilet; utilize an authorized community drug take-back program instead.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Pro-Cure found in:

A-Z Index: